["{\n\"step_by_step_thinking\": \"According to the provided documents, Phase I clinical trials are conducted to establish a maximum tolerated dose (MTD) and a tolerable dose range for future efficacy testing. This information is mentioned in 'Phase I cancer trials: limitations and implications'. The goal of these trials is not to evaluate efficacy, but rather to determine the MTD and risk-benefit ethical issues.\",\n\"answer_choice\": \"A\""]